ITGAM Monoclonal Antibody,FITC Conjugated
- 
								中文名稱:ITGAM鼠單克隆抗體,FITC偶聯(lián)
- 
								貨號:CSB-MA270358
- 
								規(guī)格:¥1760
- 
								其他:
產(chǎn)品詳情
- 
                                            產(chǎn)品描述:ITGAM(整合素αM)作為CD11b的核心組成成分,在介導白細胞黏附、遷移及免疫調(diào)節(jié)中發(fā)揮關(guān)鍵作用,其異常表達與炎癥反應(yīng)、自身免疫性疾病及腫瘤微環(huán)境調(diào)控密切相關(guān)。本產(chǎn)品CUSABIO貨號:CSB-MA270358為FITC熒光標記的人源ITGAM單克隆抗體,采用雜交瘤技術(shù)制備,具有精準的抗原結(jié)合位點和穩(wěn)定的熒光標記特性,適用于流式細胞術(shù)(FC)、免疫熒光(IF)及酶聯(lián)免疫吸附(ELISA)等多維檢測平臺。經(jīng)嚴格驗證的種屬特異性確保對人源樣本中ITGAM蛋白的準確識別,可有效應(yīng)用于免疫細胞亞群分析、炎癥信號通路研究、巨噬細胞功能表征等科研場景。該抗體特別適合需要高靈敏度檢測ITGAM表面表達的實驗設(shè)計,為探索感染性疾病機制、腫瘤免疫微環(huán)境研究及免疫調(diào)控網(wǎng)絡(luò)解析提供可靠工具。作為專業(yè)科研試劑,本產(chǎn)品滿足分子互作研究、細胞表型鑒定等基礎(chǔ)研究需求,是開展免疫相關(guān)疾病機制研究的優(yōu)選工具。
- 
											宿主:Mouse
- 
											反應(yīng)種屬:Human
- 
											免疫原:
- 
											免疫原種屬:Homo sapiens (Human)
- 
											克隆類型:Monoclonal
- 
											抗體亞型:IgG1
- 
											克隆號:14C12
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											產(chǎn)品提供形式:Phosphate-buffered solution, pH 7.4, containing 0.09% sodium azide and 0.2% (w/v) BSA
- 
											應(yīng)用范圍:ELISA,IF,FC
- 
											推薦稀釋比:Application Recommended Dilution IF 1:100-1:200 
- 
											Protocols:
- 
											儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Most popular with customers
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
 













 
         
           
  
          